# Continuous Glucose Monitoring Devices in Hospitalized Veterans With Diabetes

Study · id `cardio:ct-nct03508934` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03508934](<https://clinicaltrials.gov/study/NCT03508934>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03508934

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 218 participants.

## Technical summary

Registry record NCT03508934. Randomized; no masking; primary purpose prevention. Start 2018-07-01 (actual); primary completion 2025-07-11 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 218 participants (enrolled count; ClinicalTrials.gov record NCT03508934, source copy `cardio:ctgov-nct03508934-2026-01-07`, retrieved 2026-10-26)
- Started: 2018-07-01 (actual) (ClinicalTrials.gov record NCT03508934, source copy `cardio:ctgov-nct03508934-2026-01-07`, retrieved 2026-10-26)
- Primary completion: 2025-07-11 (actual) (ClinicalTrials.gov record NCT03508934, source copy `cardio:ctgov-nct03508934-2026-01-07`, retrieved 2026-10-26)
- Completion: 2026-04-30 (anticipated) (ClinicalTrials.gov record NCT03508934, source copy `cardio:ctgov-nct03508934-2026-01-07`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT03508934, source copy `cardio:ctgov-nct03508934-2026-01-07`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03508934-2026-01-07`, retrieved 2026-10-26)

## The registry's words

- Brief title: Continuous Glucose Monitoring Devices in Hospitalized Veterans With Diabetes
- Condition: Diabetes Mellitus, Type 2
- Condition: Hypoglycemia
- Intervention (Device): GTS (Continuous Glucose Monitoring)
- Intervention (Other): POC (Point of Care)
- Lead sponsor: VA Office of Research and Development
- Lead sponsor class: FED

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: VA Office of Research and Development (`cardio:org-va-office-of-research-and-development`)

## Provenance

Content hash: cc2e7a76a754e540764f43455bf9f339d96dbf0b5162dd219c1386ad62dcceb4
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
